Underlying Hb in submucosa
Urobilinogen and stercobilinogen Smooth muscle Little myoglobin, Hb, unknown?
Bilirubin and
urobilinogen concentrations in urine were increased in samples from Nigerian patients with malaria, compared to uninfected patients (P < 0.05) [11].
Urine analysis revealed a specific gravity of 1005, albumin: nil,
urobilinogen: normal trace, pH 6.5, pus cells 2-3/HPF, RBCs 8-10/HPF, SGOT 11 U/L, SGPT 35 U/L, and total bilirubin 0.7 mg/dl.
Urinalysis: Color Dark Yellow Appearance Cloudy Albumin Negative Bilirubin Negative Glucose Negative Ketones Negative Nitrite Positive Occult blood Negative pH 5.6 Odor Fetid Protein 1+ Specific grav 1.020
Urobilinogen Negative Cells: Erythrocytes 2 Leukocytes 7 Epithelium 8 Casts Moderate Crystals Small amount Bacteria Large amount Parasites None 1.
Urinalysis on the first day of admission showed specific gravity 1.007, pH 5.5, urine leukocyte esterase 3+, urine nitrite negative, protein 1 +, glucose negative, ketones negative,
urobilinogen [less than or equal to] 0.2 mg/dL, bilirubin negative, occult blood 3 +, white blood cell count >100/ high power field, bacteria moderate, red blood cell negative, a few amorphous crystals, and a few white blood cell clumps.
Laboratory investigations revealed hemoglobin level 10.8g%, platelet count 1.5L/cumm, total bilirubin 5.2 mg/dl, ALT 46IU, AST42IU/L, urine was negative for
urobilinogen, bilepigments and bilesalts.
Urobilinogen test abnormalities were observed in 274 (33.5%) of these crewmembers.
Urine was anonymously tested by Combur 10 Test D dipstick (Roche Diagnostics, Basel, Switzerland) for the following: specific gravity, leucocytes, nitrites, proteins, glucose, ketones,
urobilinogen, bilirubin, blood, and haemoglobin.
Urinary and fecal
urobilinogen level is increased because of destruction of bilirubin.
The app enables a mobile phone to analyze urine dipsticks "for the qualitative and semi-quantitative determination of urine analytes including glucose,
urobilinogen, pH, ketone, blood, protein, bilirubin, nitrite leukocyte, and specific gravity." The letter required the company to explain to FDA why its mobile app was not a medical device subject to clearance under section 510(k) of the FD&C Act.